Aimee Stablewski
Impact in
-
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- RNA modifications and cancer
- FOXO transcription factor regulation
- Genomics and Chromatin Dynamics
-
- Genetic Syndromes and Imprinting
Papers in
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 3
- Renal and related cancers 2
- Genomics and Chromatin Dynamics 2
- Epigenetics and DNA Methylation 2
- Genetics 3
- Genetic Syndromes and Imprinting 2
- Co-authors
- Adam R. Karpf (2 shared papers)Carter J. Barger (2 shared papers)Michael J. Higgins (2 shared papers)Kunle Odunsi (2 shared papers)Dmitri Loukinov (2 shared papers)Victor V. Lobanenkov (2 shared papers)Barbara C. Vanderhyden (1 shared paper)Wa Zhang (1 shared paper)
- Journals
- Science Advances (2 papers)Oncotarget (2 papers)iScience (1 paper)Molecular Therapy — Oncolytics (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesRussiaPoland
In The Last Decade
Aimee Stablewski
17 papers receiving 376 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 300
- Genetics 98
- Virology 16
- Cancer Research 39
- Aging 4
Countries citing papers authored by Aimee Stablewski
This map shows the geographic impact of Aimee Stablewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee Stablewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee Stablewski more than expected).
Fields of papers citing papers by Aimee Stablewski
This network shows the impact of papers produced by Aimee Stablewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee Stablewski. The network helps show where Aimee Stablewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimee Stablewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 82 | |
| 2 | 2015 | 59 | |
| 3 | 2020 | 44 | |
| 4 | 2020 | 23 | |
| 5 | 2021 | 23 | |
| 6 | 2019 | 23 | |
| 7 | 2019 | 22 | |
| 8 | 2023 | 22 | |
| 9 | 2022 | 18 | |
| 10 | 2010 | 17 | |
| 11 | 2021 | 11 | |
| 12 | 2014 | 11 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2025 | 0 |
About Aimee Stablewski
Aimee Stablewski is a scholar working on Molecular Biology, Genetics, Immunology, Surgery and Epidemiology, having authored 18 papers that have together received 379 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Pluripotent Stem Cells Research (3 papers), Renal and related cancers (2 papers), Genomics and Chromatin Dynamics (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Genetic Syndromes and Imprinting (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Molecular Biology (300 citations), Genetics (98 citations), Virology (16 citations), Cancer Research (39 citations) and Aging (4 citations). Aimee Stablewski has collaborated with scholars based in United States, Russia and Poland. Frequent co-authors include Adam R. Karpf, Carter J. Barger, Michael J. Higgins, Kunle Odunsi, Dmitri Loukinov, Victor V. Lobanenkov, Barbara C. Vanderhyden, Wa Zhang, Herry Herman and Anders M. Lindroth. Their work appears in journals such as Science Advances, Oncotarget, iScience, Molecular Therapy — Oncolytics and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.